These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26687272)

  • 1. Assessment of a multi-assay biological diagnostic test for mood disorders in a Japanese population.
    Yamamori H; Ishima T; Yasuda Y; Fujimoto M; Kudo N; Ohi K; Hashimoto K; Takeda M; Hashimoto R
    Neurosci Lett; 2016 Jan; 612():167-171. PubMed ID: 26687272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence and illness characteristics of DSM-5-defined "mixed feature specifier" in adults with major depressive disorder and bipolar disorder: Results from the International Mood Disorders Collaborative Project.
    McIntyre RS; Soczynska JK; Cha DS; Woldeyohannes HO; Dale RS; Alsuwaidan MT; Gallaugher LA; Mansur RB; Muzina DJ; Carvalho A; Kennedy SH
    J Affect Disord; 2015 Feb; 172():259-64. PubMed ID: 25451425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of TNF-α, soluble TNF receptors (sTNFR1, sTNFR2), and cognition in bipolar disorder.
    Doganavsargil-Baysal O; Cinemre B; Aksoy UM; Akbas H; Metin O; Fettahoglu C; Gokmen Z; Davran F
    Hum Psychopharmacol; 2013 Mar; 28(2):160-7. PubMed ID: 23532748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.
    Papakostas GI; Shelton RC; Kinrys G; Henry ME; Bakow BR; Lipkin SH; Pi B; Thurmond L; Bilello JA
    Mol Psychiatry; 2013 Mar; 18(3):332-9. PubMed ID: 22158016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a blood-based diagnostic panel for bipolar disorder.
    Haenisch F; Cooper JD; Reif A; Kittel-Schneider S; Steiner J; Leweke FM; Rothermundt M; van Beveren NJM; Crespo-Facorro B; Niebuhr DW; Cowan DN; Weber NS; Yolken RH; Penninx BWJH; Bahn S
    Brain Behav Immun; 2016 Feb; 52():49-57. PubMed ID: 26441135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers.
    Koutsouleris N; Meisenzahl EM; Borgwardt S; Riecher-Rössler A; Frodl T; Kambeitz J; Köhler Y; Falkai P; Möller HJ; Reiser M; Davatzikos C
    Brain; 2015 Jul; 138(Pt 7):2059-73. PubMed ID: 25935725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the immune-inflammatory profiles of unipolar and bipolar depression.
    Brunoni AR; Supasitthumrong T; Teixeira AL; Vieira EL; Gattaz WF; Benseñor IM; Lotufo PA; Lafer B; Berk M; Carvalho AF; Maes M
    J Affect Disord; 2020 Feb; 262():8-15. PubMed ID: 31693974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression.
    Tomasik J; Harrison SJ; Rustogi N; Olmert T; Barton-Owen G; Han SYS; Cooper JD; Eljasz P; Farrag LP; Friend LV; Bell E; Cowell D; Bahn S
    JAMA Psychiatry; 2024 Jan; 81(1):101-106. PubMed ID: 37878349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the combined application of the Mood Disorder Questionnaire and Bipolar Spectrum Diagnostic Scale in screening for bipolar disorder.
    Lee D; Cha B; Park CS; Kim BJ; Lee CS; Lee S
    Compr Psychiatry; 2013 May; 54(4):334-40. PubMed ID: 23151598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression.
    Kageyama Y; Kasahara T; Kato M; Sakai S; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Goto Y; Kinoshita T; Inoue K; Kato T
    J Affect Disord; 2018 Jun; 233():15-20. PubMed ID: 28633757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling of the Peripheral Blood Mononuclear Cell Proteome in Schizophrenia and Mood Disorders for the Discovery of Discriminatory Biomarkers: A Proof-of-Concept Study.
    Coppens V; De Wachter O; Goossens J; Hendrix J; Maudsley S; Azmi A; van Gastel J; Van Saet A; Lauwers T; Morrens M
    Neuropsychobiology; 2020; 79(4-5):324-334. PubMed ID: 32392557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder.
    Barbosa IG; Huguet RB; Mendonça VA; Sousa LP; Neves FS; Bauer ME; Teixeira AL
    Eur Arch Psychiatry Clin Neurosci; 2011 Mar; 261(2):139-43. PubMed ID: 20446090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased soluble tumor necrosis factor-alpha receptors in patients with major depressive disorder.
    Grassi-Oliveira R; Brietzke E; Pezzi JC; Lopes RP; Teixeira AL; Bauer ME
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):202-8. PubMed ID: 19175760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder.
    Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS
    World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Executive dysfunction in euthymic bipolar disorder patients and its association with plasma biomarkers.
    Barbosa IG; Rocha NP; Huguet RB; Ferreira RA; Salgado JV; Carvalho LA; Pariante CM; Teixeira AL
    J Affect Disord; 2012 Mar; 137(1-3):151-5. PubMed ID: 22252095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complexity analysis of spontaneous brain activity in mood disorders: A magnetoencephalography study of bipolar disorder and major depression.
    Fernández A; Al-Timemy AH; Ferre F; Rubio G; Escudero J
    Compr Psychiatry; 2018 Jul; 84():112-117. PubMed ID: 29734005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders.
    Dean B; Gibbons AS; Tawadros N; Brooks L; Everall IP; Scarr E
    Mol Psychiatry; 2013 Jul; 18(7):767-73. PubMed ID: 22801413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Search for plasma biomarkers in drug-free patients with bipolar disorder and schizophrenia using metabolome analysis.
    Kageyama Y; Kasahara T; Morishita H; Mataga N; Deguchi Y; Tani M; Kuroda K; Hattori K; Yoshida S; Inoue K; Kato T
    Psychiatry Clin Neurosci; 2017 Feb; 71(2):115-123. PubMed ID: 27676126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bipolar disorder moderates associations between linoleic acid and markers of inflammation.
    Chang YW; Assari S; Prossin AR; Stertz L; McInnis MG; Evans SJ
    J Psychiatr Res; 2017 Feb; 85():29-36. PubMed ID: 27821270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.